245 Participants Needed

Repository for Cervical Myelopathy

(DCM Trial)

JH
Francis Farhadi, MD, PhD profile photo
Overseen ByFrancis Farhadi, MD, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Kentucky
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to gather information from individuals with degenerative cervical myelopathy (DCM), a condition where the spinal cord in the neck is compressed, and compare it to those with other spinal issues but without DCM symptoms. By doing so, researchers hope to better predict DCM progression and patient responses to treatments. Participants will undergo standard clinical care procedures, and their outcomes will be measured. Ideal candidates for the trial include those diagnosed with DCM or those with cervical spinal disease but without myelopathy (symptoms affecting the spinal cord). As an unphased trial, this study offers participants the chance to contribute to foundational research that could enhance future DCM diagnosis and treatment strategies.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to deepen our understanding of degenerative cervical myelopathy (DCM) compared to other cervical spinal diseases. Unlike standard treatments that focus on alleviating symptoms through surgery or medication, this trial explores comprehensive clinical care procedures and outcome measurements to better differentiate between DCM and non-myelopathic conditions. By analyzing these differences, researchers hope to improve diagnosis and tailor treatments more effectively, ultimately enhancing patient care.

Are You a Good Fit for This Trial?

Inclusion Criteria

Diagnosis of degenerative cervical myelopathy
Diagnosis of cervical degenerative disease without myelopathy

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Data Collection

Participants' functional and biological measures are assessed to create a research repository

2 years

Follow-up

Participants are monitored for symptomatic progression and response to treatment

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Standard clinical care procedures and outcome measurements
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: DCM groupExperimental Treatment1 Intervention
Group II: Control groupExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Kentucky

Lead Sponsor

Trials
198
Recruited
224,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security